Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Cai CX, Hribar M, Baxter S, Goetz K, Swaminathan SS, Flowers A, Brown EN, Toy B, Xu B, Chen J, Chen A, Wang S, Lee C, Leng T, Ehrlich JR, Barkmeier A, Armbrust KR, Boland MV, Dorr D, Boyce D, Alshammari T, Swerdel J, Suchard MA, Schuemie M, Bu F, Sena AG, Hripcsak G, Nishimura A, Nagy P, Falconer T, DuVall SL, Matheny M, Viernes B, O'Brien W, Zhang L, Martin B, Westlund E, Mathioudakis N, Fan R, Wilcox A, Lai A, Stocking JC, Takkouche S, Lee LH, Xie Y, Humes I, McCoy DB, Adibuzzaman M, Areaux RG, Rojas-Carabali W, Brash J, Lee DA, Weiskopf NG, Mawn L, Agrawal R, Morgan-Cooper H, Desai P, Ryan PB. Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. JAMA Ophthalmol. 2025 Apr 01; 143(4):304-314.
-
De P, Khine MT, Frankel A, Goldet G, Banerjee D, Montero RM, Chowdhury TA, Fogarty D, Karalliedde J, Mallik R, Patel DC, Wahba M, Winocour P, Zac-Varghese S, Bain S, Sharif A, Bellary S, Dasgupta I. Finerenone in the management of diabetes kidney disease. BMC Nephrol. 2025 Feb 08; 26(1):63.
-
Amaral DC, Guedes J, Cruz MRB, Cheidde L, Nepomuceno M, Magalh?es PLM, Brazuna R, Mora-Paez DJ, Huang P, Razeghinejad R, Schuman JS, Myers JS. GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis. Am J Ophthalmol. 2025 Mar; 271:488-497.
-
Rovner BW, Casten RJ. Discordant Medication Beliefs in Black Individuals With Mild Cognitive Impairment and Diabetes. Am J Geriatr Psychiatry. 2025 Apr; 33(4):337-341.
-
Li M, Perlov NM, Patel J, Amin D, Kumar A, Urdang ZD, Willcox TO, Chiffer RC. Association of type 2 diabetes mellitus with sensorineural hearing loss - A population-based analysis. Neuro Endocrinol Lett. 2024 Nov 28; 45(5):341-351.
-
Simonson DC, Testa MA, Ekholm E, Su M, Vilsb?ll T, Jabbour SA, Lind M. Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine. J Clin Endocrinol Metab. 2024 Nov 18; 109(12):e2261-e2272.
-
Qian F, Guo Y, Li C, Liu Y, Luttmann-Gibson H, Gomelskaya N, Demler OV, Cook NR, Lee IM, Buring JE, Larsen J, Boring J, McPhaul MJ, Manson JE, Pradhan AD, Mora S. Biomarkers of glucose-insulin homeostasis and incident type 2 diabetes and cardiovascular disease: results from the Vitamin D and Omega-3 trial. Cardiovasc Diabetol. 2024 11 02; 23(1):393.
-
Dasgupta I, Zac-Varghese S, Chaudhry K, McCafferty K, Winocour P, Chowdhury TA, Bellary S, Goldet G, Wahba M, De P, Frankel AH, Montero RM, Lioudaki E, Banerjee D, Mallik R, Sharif A, Kanumilli N, Milne N, Patel DC, Dhatariya K, Bain SC, Karalliedde J. Current management of chronic kidney disease in type-2 diabetes-A tiered approach: An overview of the joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) guidelines. Diabet Med. 2025 Feb; 42(2):e15450.
-
Amiri Roudbar M, Vahedi SM, Jin J, Jahangiri M, Lanjanian H, Habibi D, Masjoudi S, Riahi P, Fateh ST, Neshati F, Zahedi AS, Moazzam-Jazi M, Najd-Hassan-Bonab L, Mousavi SF, Asgarian S, Zarkesh M, Moghaddas MR, Tenesa A, Kazemnejad A, Vahidnezhad H, Hakonarson H, Azizi F, Hedayati M, Daneshpour MS, Akbarzadeh M. The effect of family structure on the still-missing heritability and genomic prediction accuracy of type 2 diabetes. Hum Genomics. 2024 09 11; 18(1):98.
-
Kelly MS, Scopelliti EM, Goodson KE, Lo CMA, Nguyen HX, Simon B. Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2024 12; 26(12):5661-5668.